Market Value2,897,047,000
Total Holdings80
File Date2022-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARQT / Arcutis Biotherapeutics, Inc.
TSVT / 2seventy bio, Inc.
MRTX / Mirati Therapeutics, Inc.
NUVB / Nuvation Bio Inc.
RVMD / Revolution Medicines, Inc.
EXEL / Exelixis, Inc. Call
RETA / Reata Pharmaceuticals Inc - Class A
MRSN / Mersana Therapeutics, Inc.
PRTA / Prothena Corporation plc
MORF / Morphic Holding, Inc.
EVLO / Evelo Biosciences, Inc.
GERN / Geron Corporation
ITOS / iTeos Therapeutics, Inc.
SBTX / Silverback Therapeutics Inc
CERE / Cerevel Therapeutics Holdings, Inc.
SLDB / Solid Biosciences Inc.
ERAS / Erasca, Inc.
NGM / NGM Biopharmaceuticals, Inc.
EUCR / Eucrates Biomedical Acquisition Corp
ARGX / argenx SE - Depositary Receipt (Common Stock)
RCUS / Arcus Biosciences, Inc.
BLSA / BCLS Acquisition Corp - Class A
KNTE / Kinnate Biopharma Inc.
TMPM / Turmeric Acquisition Corp - Class A
FVAM / 5:01 Acquisition Corp.
FLAC / Frazier Lifesciences Acquisition Corp - Class A
XNCR / Xencor, Inc.
EXEL / Exelixis, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
ORIC / ORIC Pharmaceuticals, Inc.
FRAZIER LIFESCIENCES ACQU CO / *W EXP 11/30/202 (G3710A113)
PARDES BIOSCIENCES INC / (69945Q105)
IGMS / IGM Biosciences, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
KYG9127T1242 / WARRANTS
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
JYAC / Jiya Acquisition Corp - Class A
/ VENTYX BIOSCIENCES INC
HLXA / Helix Acquisition Corp - Class A
RPTX / Repare Therapeutics Inc.
RDUS / Radius Recycling, Inc.
CCCC / C4 Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
CRBU / Caribou Biosciences, Inc.
NRIX / Nurix Therapeutics, Inc.
AMTI / Applied Molecular Transport Inc.
BCEL / Atreca, Inc.
PMVP / PMV Pharmaceuticals, Inc.
ACIU / AC Immune SA
OLMA / Olema Pharmaceuticals, Inc.
KDNY / Chinook Therapeutics Inc
DTIL / Precision BioSciences, Inc.
CGEM / Cullinan Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
OMEG / Omega Alpha SPAC - Class A
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
SGEN / Seagen Inc
PRAX / Praxis Precision Medicines, Inc.
INCY / Incyte Corporation
HOOK / HOOKIPA Pharma Inc.
CMAXW / CareMax Inc - Warrants (08/06/2026)
ADVM / Adverum Biotechnologies, Inc.
VGG3141W1225 / Eucrates Biomedical Acquisition Corp. Call
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
SELB / Selecta Biosciences Inc
AVEO / AVEO Pharmaceuticals Inc
ALLO / Allogene Therapeutics, Inc.
TPST / Tempest Therapeutics, Inc.
OVID / Ovid Therapeutics Inc.
ALEC / Alector, Inc.
PCVX / Vaxcyte, Inc.
DSGN / Design Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
AKUS / Akouos Inc
SURF / Surface Oncology Inc
EWTX / Edgewise Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
KRON / Kronos Bio, Inc.
GRPH / Graphite Bio, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
SRPT / Sarepta Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
RNA / Avidity Biosciences, Inc.
ANAB / AnaptysBio, Inc.
ALGS / Aligos Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
KURA / Kura Oncology, Inc.
CLDX / Celldex Therapeutics, Inc. Put
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
VERV / Verve Therapeutics, Inc.
AVIR / Atea Pharmaceuticals, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
TNGX / Tango Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
ARVN / Arvinas, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
VYGR / Voyager Therapeutics, Inc.